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(OLN) are a new class of nanodevices to effectively deliver anti-cancer drugs to
tumoral cells. This study investigated their antitumoral effects 'per se', using a
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Methods: OLN were prepared and characterized either in vitro or in vivo. TUBO cells,
established from a lobular carcinoma of a BALB-neuT mouse, were investigated
following 48 h of incubation in the absence/presence of different concentrations of
OLN. OLN internalization, cell viability, necrosis, apoptosis, cell cycle and reactive
oxygen species (ROS) production were checked as described in the Method section.
In vivo tumor growth was evaluated after subcutaneous transplant in BALB/c mice of
TUBO cells either without treatment or after 24 h incubation with 10% v/v OLN.
Results: OLN showed sizes of about 350 nm and a positive surface charge (45 mV).
Dose-dependent TUBO cell death through ROS-triggered apoptosis following OLN
internalization was detected. A mathematical model predicting the effects of OLN
uptake was validated on both in vitro and in vivo results.
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Conclusion: due to their intrinsic toxicity OLN might be considered an adjuvant tool
suitable to deliver their therapeutic cargo intracellularly and may be proposed as
promising combined delivery system.
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Dear Editor, 
We resubmit the manuscript ‘IN VITRO’, ‘IN VIVO’ AND ‘IN SILICO’ INVESTIGATION OF THE 
ANTICANCER EFFECTIVENESS OF OXYGEN-LOADED CHITOSAN-SHELLED NANODROPLETS 
AS POTENTIAL DRUG VECTOR after a careful revision based on the useful and helpful reviewers’ 
observations. 
In particular, we completely re-drawn Figure 4 and we commented the MTT values in the text. Moreover, two 
papers are inserted in bibliography. 
The detailed answers to the reviewers’ comments follow. 
 
REVIEWER 3: 
According to reviewer’s suggestion, figure 4 was completely modified with an higher quality. The results of 
MTT test were commented in the manuscript: 
 
“OLN  inhibit TUBO cells cell growth 
 
In order to evaluate the OLN effects on cell growth, TUBO cells  treated with increasing doses (2.5%, 5%, 
10%, 20% and 40% v/v) of  OLN aqueous nanosuspensions were  monitored for 24, 48 and 72 hours by MTT 
assay. OLN treatment reduced the viability of TUBO cells in a concentration- and time-dependent manner. 
Interestingly, no significant inhibition of cell proliferation was observed up to 10%-OLN dose. The highest 
growth inhibition was reached after 48 hours of treatment with 40% v/v of OLN, which induced 
approximately a 90% reduction in cell viability respect to controls. On the other hand, the incubation with 
20% v/v of OLN induced only about 30% of inhibition of cell viability. 
Based on these results, the doses corresponding to 20% and 40% v/v of OLN were not considered for 
further experiments.” 
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Abstract  
 
 
Purpose: Chitosan-shelled/decafluoropentane-cored oxygen-loaded nanodroplets (OLN) are a new 
class of nanodevices to effectively deliver anti-cancer drugs to tumoral cells. This study 
investigated their antitumoral effects ‘per se’, using a mathematical model validated on 
experimental data.  
Methods: OLN were prepared and characterized either in vitro or in vivo. TUBO cells, established 
from a lobular carcinoma of a BALB-neuT mouse, were investigated following 48 h of incubation 
in the absence/presence of different concentrations of OLN. OLN internalization, cell viability, 
necrosis, apoptosis, cell cycle and reactive oxygen species (ROS) production were checked as 
described in the Method section.  
In vivo tumor growth was evaluated after subcutaneous transplant in BALB/c mice of TUBO cells 
either without treatment or after 24 h incubation with 10% v/v OLN.  
Results: OLN showed sizes of about 350 nm and a positive surface charge (45 mV). Dose-
dependent TUBO cell death through ROS-triggered apoptosis following OLN internalization was 
detected. A mathematical model predicting the effects of OLN uptake was validated on both in vitro 
and in vivo results. 
Conclusion: due to their intrinsic toxicity OLN might be considered an adjuvant tool suitable to 
deliver their therapeutic cargo intracellularly and may be proposed as promising combined delivery 
system. 
 
Keywords: Chitosan nanodroplet, antitumor nanodevice, nanocarrier, breast cancer, oxygen 
 
Abbreviations 
DAPI = Diamidino-2-phenylindole dihydrochloride 
DMEM = Dulbecco’s Modified Eagle Medium 
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FITC = fluorescein isothiocyanate 
LDH= lactate dehydrogenase  
MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
OLN = Oxygen-loaded Nanodroplets 
ROS = Oxygen Reactive Species 
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Introduction 
Innovative drug delivery nanodevices can improve the pharmacokinetics and biodistribution of 
chemoterapeutics (1). Since cells can internalize small  materials (2), drug delivery systems at the 
nanoscale range are expected to provide new interesting therapeutic approaches (3). Nanoparticle 
sizes are small enough to allow intra- or trans-capillary passage while surface modification can be 
tuned to avoid macrophage uptake and to favour the accumulation in specific tissues. Nanoparticles, 
when properly synthesized from biodegradable materials (4), can be biocompatible and improve the 
stability of active compounds. Furthermore, they can overcome drug resistance issues by greatly 
improving drug effectiveness and reducing chances for side effects to arise (1, 5). Hypoxia-
activated, near-infrared (NIR) light-triggered chitosan nanoparticles have been developed to deliver 
drugs to cancer cells (6). Recently, a new class of nanodevices for oxygen storage and release has 
been designed, namely perfluoropentane-based oxygen-loaded nanobubbles and decafluoropentane-
based oxygen-loaded nanodroplets (7, 8). Both nanodevices, coated with biocompatible and 
biodegradable polysaccharides such as dextran sulfate or chitosan, proved to be effective in oxygen 
delivery either in vitro or in vivo (7-10). Chitosan-shelled/decafluoropentane-cored oxygen-loaded 
nanodroplets (OLN), having average diameters of about 700 nm, positive charge and long-term 
stability (7) have been designed as potential therapeutic tools to promote healing processes in 
infected chronic wounds, since chitosan-based OLN displayed antimicrobial properties against 
methylcillin-resistant Staphylococcus aureus and Candida albicans (11). Interestingly, this types of 
OLN showed the capability to overcome hypoxia-dependent dysregulation of matrix-associated 
proteolytic enzymes such as matrix metalloproteinases (12). 
In the present study the effects of chitosan-shelled OLN on the growth of TUBO breast cancer cells 
will be designed either in vitro or in vivo. OLN internalization by TUBO cells was investigated and 
its effectiveness on cell viability along with some possible underlying mechanisms was assessed 
with the aim to define the key parameters. For this purpose, a simple mathematical model 
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 5 
simulating the OLN uptake by TUBO cells and their cell interactions was developed to describe the 
crucial role played by nanodroplet internalization on the cell viability.  
 
Materials and Methods  
Materials 
Unless otherwise stated, all materials were from Sigma-Aldrich (St Louis, MO). Ethanol (96%) was 
from Carlo Erba (Milan, Italy); Epikuron 200® (soya phosphatidylcholine 95%) was from Degussa 
(Hamburg, Germany); palmitic acid, decafluoropentane (DFP), chitosan, and polyvinylpyrrolidone 
(PVP) were from Fluka (Buchs, Switzerland); ultrapure water was obtained using a 1-800 Millipore 
system (Molsheim, France); Ultra-Turrax SG215 homogenizer was from IKA (Staufen, Germany); 
PEN-STREP was from Cambrex Bio Science (Vervies, Belgium); LSM710 inverted confocal laser 
scanning microscope was from Carl Zeiss (Oberkochen, Germany); Synergy HT microplate reader 
was from Bio-Tek Instruments (Winooski, VT); FACScan flow cytometer and CellQuest software 
were from Becton & Dickinson (Mountain View, CA); SPSS 16.0 software from SPSS (Chicago, 
IL, USA). TUBO cells were kindly provided by Dr. Laura Conti, Molecular Biotechnology Center, 
University of Torino. BALB/c mice were bred under specific pathogen-free conditions (Allentown 
Caging Equipment, Allentown, NJ) at the Molecular Biotechnology Center and treated according to 
current European guidelines and policies. The experimental plan was approved by the Bioethical 
Committee of the University of Torino. 
 
Preparation of FITC-labeled chitosan 
FITC-labeled chitosan was obtained by the reaction between the isothiocyanate group of FITC and 
the primary amine group of the d-glucosamine residue of chitosan. For this purpose, one gram of 
chitosan was dissolved in 100 ml of 0.10 M acetic acid. To the chitosan solution, 100 ml of 
dehydrated methanol was slowly added with continuous stirring. A FITC methanol solution (2 
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 6 
mg/ml), was slowly added to the chitosan solution. The reaction was allowed to proceed for 3 h in 
the dark at room temperature. FITC-labeled chitosan was precipitated in 0.1 M sodium hydroxide 
solution. The precipitate was washed extensively with deionized distilled water, to eliminate free 
FITC. The labeled polymer was then freeze dried.  
 
Preparation of chitosan-shelled/decafluoropentane-cored OLN 
 
Chitosan-shelled/decafluoropentane-cored (OLN) were prepared as previously described using a 
two-step method (7, 8). At first, a decafluoropentane nanoemulsion was obtained and stabilized with 
dipalmitoylphosphatidylcholine and palmitic acid (1% w/v). The nanoemulsion was saturated with 
oxygen, up to a gas concentration of 30 mg/L. Subsequently, a chitosan solution (2.7% w/v) at pH = 
5.5 was added dropwise under stirring, maintaining the oxygen purge up to 30 mg/L. 
Fluorescent-labelled OLN were then prepared with the same preparation protocol above described 
but using fluorescein isothiocyanate (FITC)-chitosan for the shell. 
The two OLN formulations were sterilized through ultraviolet (UV)-C ray exposure for 20 min. To 
control the sterilization efficacy, UV-C treated OLN were incubated with cell culture DMEM 
medium in a humidified CO2/air incubator at 37°C up to 72 h. No signs of microbial contamination 
were observed when OLN and FITC-labeled OLN were checked by optical microscopy.  
 
Physico-chemical characterization of chitosan-shelled/decafluoropentane-cored OLN 
 
Blank-unlabelled and fluorescent-labelled OLN formulations were in vitro characterized to evaluate 
size, morphology and surface charge. The average diameter and polydispersity index of the OLN 
formulations were measured by photocorrelation spectroscopy (PCS) using a 90 Plus instrument 
(Brookhaven, NY, USA) at a fixed angle of 90◦ and a temperature of 25 °C after dilution with 
filtered water. Each value represents the average of five measurements of three different sample 
batches. For zeta potential determination, the diluted OLN formulations were placed in an 
electrophoretic cell, where a rounded 15 V/cm electric field was applied. Each value reported is the 
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 7 
average of ten measurements of three different formulations. The morphology of unlabelled-OLN 
formulations was determined by transmission electron microscopy (TEM) analysis performed using 
a Philips CM10 instrument (Eindhoven, NL). Nanodroplet preparations were dropped onto a 
Formvar-coated copper grid and air-dried prior to examination.  
 
 In vitro oxygen release from chitosan-shelled/decafluoropentane-cored (OLN) 
In vitro oxygen release from chitosan-shelled/decafluoropentane-cored OLN was investigated using 
the dialysis bag technique. The donor phase, consisting of 3 mL of OLN formulation, was placed in 
a dialysis bag (cellulose membrane, molecular weight of 12–14,000 Da), hermetically sealed and 
immersed in 45 mL of the receiving phase. The receiving phase consisted of 0.9% (w/v) NaCl 
(saline) solution whit a oxygen concentration of 4 mg/L. The oxygen concentration was previously 
reduced with a N2 purge in order to mimic hypoxic conditions. Then, the oxygen release kinetics 
from OLN was monitored for 8 hours, using an oxymeter (HQ40d model, Hach) at 37 °C. 
 
Cell cultures 
TUBO cells, a cloned rat Her2/neu+ cell line established from a lobular carcinoma of a BALB-neuT 
mouse (13) were cultured in high glucose DMEM, containing 20% fetal bovine serum (FBS), 2 mM 
L-glutamine and 1 % penicillin-streptomycin (PEN-STRE TEMP) in a humidified CO2/air-
incubator at 37°C. 
 
Evaluation of OLN uptake by TUBO cells 
TUBO cells were plated in 6-well plates on glass coverslips and incubated in DMEM medium for 
24 h with/without 10% v/v FITC-labelled OLN in a humidified CO2/air-incubator at 37°C. The 
procedure followed is fully described in (8). 
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Cell viability assay 
Cell viability was checked by MTT assay. Cells were seeded at 4×104 cells/200 μl of medium per 
well in 96-well plates. Twenty-four hours after plating, cells were left untreated or treated with 
various doses of OLN (2.5 %, 5%, 10%, 20%, 40% v/v) up to 72 hours. Thereafter, each well 
received 5 μl of fresh MTT (5mg/ml in PBS) followed by incubation for 2 hr at 37°C. The 
supernatant growth medium was removed from the wells and replaced with 100 μl of DMSO to 
solubilize the dark blue formazan crystals. After 15 minutes of incubation, the absorbance (OD) of 
the culture plate was read at a wavelength of 562 nm using a Synergy HT microplate reader. 
Viability of controls was arbitrary fixed to 100%.  
 
Lactate dehydrogenase (LDH) release measurement 
The potential necrotic effect of OLN was measured as the release of lactate dehydrogenase (LDH) 
from TUBO cells into the extracellular medium. Briefly, TUBO were seeded 1x106 cells/2 ml of 
medium per well in 6-well plates. Twenty-four hours after plating, cells were incubated for 48 h in 
the presence or absence of increasing doses (2.5 %, 5%, and 10% v/v) of OLN at 37°C in a 5 % 
CO2 atmosphere. The measurement procedure is described in details in (8). 
 
Hypodiploid peak evaluation and cell cycle phase analysis  
DNA distribution analysis was performed by flow cytometry. Briefly, TUBO were seeded 1x106 
cells/2 ml of medium per well in 6-well plates. Twenty-four hours after plating, cells were incubated 
for 48 h with OLN (2.5 %, 5%, and 10% v/v). Next, TUBO cells were treated as described in (14).  
 
Reactive Oxygen Species (ROS) detection 
 
To evaluate ROS production in OLN treated TUBO cells, ROS-mediated fluorescent activation of 
the compound 5-(and 6)-carboxy-2′-7′-dichlorofluorescein diacetate (carboxy-H2DCFDA; 
Molecular Probes, Invitrogen) was measured, according to manufacturer's instructions. Briefly, cells 
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 9 
were seeded in black 96-well plates at 4 × 104 cells/200 μl of medium per well. Twenty-four hours 
after plating, cells were treated with increasing doses of OLN (2.5 %, 5%, and 10% v/v) for 24 
hours. Then, cells were supplied with carboxy-H2DCFDA (10 μM) in phenol red–free DMEM for 1 
hour, washed and incubated in phenol red–free DMEM without carboxy-H2DCFDA. Treatment 
with H2O2 (100 μM) was used as positive control. ROS generation was measured using a 
fluorescence plate reader (λex=485 nm, λem=535 nm) using a Synergy HT microplate reader. ROS 
control value was arbitrary fixed to 1. Data are expressed as fold increase compared to untreated 
control. 
 
In vivo experiments 
Ten-week-old BALB/c female mice were challenged subcutaneously in the left flank with 1x105 
TUBO cells diluted in 200 µl of PBS (control, n=5) or with 1x105 TUBO cells and 10% v/v OLN 
suspension in PBS (n=5). The mammary fat pads of all mice were inspected and palpated twice a 
week for tumor appearance and growing masses > 1 mm in mean diameter were regarded as tumors. 
Individual neoplastic masses were measured with calipers in 2 perpendicular diameters X and Y. 
Tumor mean diameter was calculated as (X+Y) / 2, and values computed on 5 mice are reported as 
mean ± SEM. Mice were sacrificed when one tumor exceeded a 10-mm mean diameter. All 
procedures were done in accordance with the EU guidelines and policies and with the approval of 
the University of Torino animal care committee (16/03/2011).  
 
Statistical analysis 
Data from MTT assay, LDH measurement, flow cytometry and ROS evaluation are expressed as the 
mean±standard deviation (SD) from three independent experiments analyzed in triplicate. Data 
from confocal microscopy are representative images from three independent experiments with 
similar results analyzed in duplicate. Statistical differences among different groups were determined 
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0 
by one-way analysis of variance (ANOVA) using SPSS 16.0 software (SPSS, Chicago, IL, USA). P 
values (p) less than 0.05 were considered as statistically significant. 
 
Mathematical model  
The simulation of the cellular uptake of nanoparticles has been tackled by Salvati and colleagues 
(15) in 2011 and the toxicity has been evaluated by Maher and collegues (16) in 2014. More 
recently, (17) Souto et al. proposed a model for simulating the localization of doxorubicin loaded 
chitosan particles in cells from which we took inspiration for the design of a simplified 
compartmental model. 
Based on experimental results, we hypothesized that: 
- OLN are internalized only by a fraction of total TUBO cells (possibly in a dose-dependent 
manner); 
- TUBO cells, which do not internalize OLN, duplicate with a rate λ= ln(2)/T which can be deduced 
by the experimental duplication time T= 36 hours. They represent the Vital (V) population. 
- in the other cell population, OLN, after internalization, interact with some intracellular ROS 
generating mechanism, which may induce, after a time delay, named t0 and related to the uptake 
time, some apoptotic phenomena.  
Toxicity decays from TOX (possibly dose dependent) to 0 with rate m (possibly related to the 
growth rate as m=k λ). For t < t0 all cells belong to V and duplicate with rate λ.  
-After t0 an Apoptotic (A) population develops constituted by the V cells which are unable to 
duplicate. However, when t >> t0 the A cells population disappears with a death rate μ. 
)2()(
)1()(
)(
)(
0
0
AVedTOX
dt
dA
VedTOXV
dt
dV
ttm
ttm






 
Both cell populations contribute to the MTT measured at different times: 
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)3(
AV
V
MTT

      
Eqns(1-3) can be solved numerically but some information can be obtained by experimental results 
In particular, two states of equilibrium are predictable. In the first one, i.e. when λ ≤ TOX(d) exp(-
m(t-to)), the OLN treatment is very effective, cell regrowth is prevented and both cell populations 
disappear. On the other hand, i.e. when λ > TOX(d) exp(-m(t-to)), the V cells population is 
restricted only for a limited time and cells regrowth is expected after a (OLN dose-dependent) time 
delay. 
 
Experimental results 
Physico-chemical characterization of chitosan-shelled/decafluoropentane-cored OLN 
The results of the physico-chemical characterization of chitosan-shelled/decafluoropentane-cored 
OLN are reported in the Table I.  
TEM image of Blank OLN showed the spherical shape and a well-defined core-shell structure of 
nanodroplets (Fig. 1). The physico-chemical characteristics of Fluorescent-labelled OLN did not 
change. 
 
[Insert Fig. 1] 
 
In vitro oxygen release from chitosan-shelled/decafluoropentane-cored OLN 
OLN ability to store and release oxygen was in vitro evaluated. Fig. 2 shows the percentage of the 
oxygen released from OLN in a hypoxic receiving chamber over time up to 8 hours. Results are 
shown as fold change of oxygen released relative to the initial concentration of 30 mg/L of the 
suspension. 
 
[Insert Fig. 2] 
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Not burst effect was observed. This behavior proved that oxygen is released by a diffusion 
mechanism from the internal core of the OLN. 
 
OLN internalization in TUBO breast cancer cells  
To study the ability of TUBO cells to internalize OLN, a confocal analysis was performed. TUBO 
cells were incubated for 24 hours with OLN shelled with FITC-labeled chitosan. After fixation and 
staining with DAPI, confocal microscopy images showed that florescent-labelled OLN were avidly 
and fast internalized by TUBO cells (Fig. 3). 
The CLSM analyses demonstrated the OLN internalization of Fluorescent-labelled OLN in TUBO 
cells. 
 
[Insert Fig. 3] 
 
OLN inhibit TUBO cells cell growth 
In order to evaluate the OLN effects on cell growth, TUBO cells  treated with increasing doses 
(2.5%, 5%, 10%, 20% and 40% v/v) of  OLN aqueous nanosuspensions were  monitored for 24, 48 
and 72 hours by MTT assay. OLN treatment reduced the viability of TUBO cells in a concentration- 
and time-dependent manner. Interestingly, no significant inhibition of cell proliferation was 
observed up to 10%-OLN dose. The highest growth inhibition was reached after 48 hours of 
treatment with 40% v/v of OLN, which induced approximately a 90% reduction in cell viability 
respect to controls. On the other hand, the incubation with 20% v/v of OLN induced only about 
30% of inhibition of cell viability. 
Based on these results, the doses corresponding to 20% and 40% v/v of OLN were not considered 
for further experiments. 
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[Insert Fig. 4] 
OLN promote apoptosis- but not necrosis-related TUBO cell death  
The effect on apoptosis and necrosis of increasing doses of OLN (2.5 %, 5%, 10% v/v) when 
incubated for 48 h with TUBO cells were measured as alternative parameters of cell death by LDH 
assay and flow cytometry, respectively (Fig. 4). As shown in panel 4A, no differences in the 
percentage of necrosis between OLN-treated (all doses) and untreated TUBO cells were observed. 
On the other hand, as shown in panels 4B, OLN promoted cell apoptosis, thus increasing the 
hypodiploid cell peak, in a dose-dependent manner, with 80% cell apoptosis being detected at the 
highest dose of OLN. 
 
Evaluation of OLN effects on TUBO cell cycle  
OLN effects on cell cycle distribution were investigated by flow cytometry. DNA content was 
measured in TUBO cells after being left untreated or treated with increasing doses (2.5 %, 5%, 10% 
v/v) of OLN nanosuspension for 48 hours. As shown in Fig. 4C, OLN did not cause any differences 
compared to controls in none of TUBO cell cycle phases (S, G0/G1, and G2/M).  
 
OLN induce ROS generation in a dose-dependent manner 
After in vitro treating TUBO cells with increasing doses of OLN nanosuspension (2.5 %, 5%, 10% 
v/v) for 24 hours, ROS generation was assessed by measuring the fluorescent activation of carboxy-
H2DCFDA. As shown in Fig. 4D, OLN enhanced ROS production with respect to untreated cells in 
a dose-dependent manner, reaching a 40% ROS increase at the highest dose. 
 
Evaluation of OLN effects on in vivo TUBO tumor growth  
An in vivo experiment was carried out to obtain the proof of concept of the OLN activity on mice 
tumor growth. From the preliminary results it seems that OLN might be able to affect tumor growth.  
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Indeed, when 10-week-old BALB/c female mice were challenged subcutaneously into the 
mammary fat pad with TUBO cells without OLN, a progressively growing tumor appeared in all 
mice. 
On the other hand, the results were different with OLN. Also it is necessary to take into account that 
high variability in tumor growth was observed when TUBO cells were inoculated in the presence of 
OLN. In two out of five mice TUBO cells did not grow, whereas in other two animals the tumor 
growth appeared strictly delayed. Only in one case the tumor growth rate was similar to that 
observed in the control group (Fig. 5). This is an explorative in vivo experiment and more animals 
would be necessary to draw a conclusion. These data can be used for the validation of the 
mathematical model. 
 
[Insert Fig. 5] 
 
Modelling results 
a. In vitro cells viability 
Fig. 6 reports the comparison between the MTT measured results for the 4 different studied doses of 
OLN and the model predictions. The parameter values were selected as: λ= 0.019 1/h; m=0.1 1/h 
(k=5.26), μ=0.001 1/h, TOX(10uM) = 0.20; TOX(20uM) = 0.22; TOX(40uM) = 0.25; TOX(80uM) 
= 0.39. 
 
[Insert Fig. 6] 
 
b. In vivo cell viability 
Fig. 7 reports the measurements (mean ± SEM) of the control group (blue line) and of the mice 
treated with OLN (exp=red points, model simulation=line). It is well evident that, after OLN 
treatment, the tumor growth is impaired with respect to the control (the red points were below the 
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blue line), and the model (black dotted line) seems able to interpolate the experimental data using 
the parameter values validated on the in vitro model (and not fitting values selected ad hoc). The 
passage from diameter (mm) to number of cells was performed according to the assumption that 1 
mm^3 = 10^6 cells.  
 
[Insert Fig. 7] 
 
Starting from the value estimated from the control group (λ=0.0096 1/h), simulations were 
performed using the same values for k, μ and TOX (20 μM) used for the in vitro model. 
Taking into account the tumor growth it is always reduced by OLN: it has been significantly slowed 
in two mice and completely stopped in other two mice. The curve predicted by the numerical 
simulation, which assumes the same parameter values of the in-vitro model, fits well with the 
experimental results and could easily be applied to reproduce each experimental dataset by properly 
adapting the parameter values. 
 
Discussion 
Much research has led to the development of nanodevices with antitumor effects and/or capability 
to selectively deliver drugs to targeted tissues, thus reducing side effects and improve drug 
effectiveness (18). The design of nanostructures able to overcome the biological barriers and to 
affect the uptake within cells have been deeply investigated (19). The in vivo nanoparticle fate 
mainly depends on the morphology, size, surface charge and chemical composition; it might be 
described using similar models, helpful tool to study and to optimize promising nanoplatforms for 
drug delivery. 
Here, chitosan shelled OLN were selected as model nanocarrier for the design of a model useful for 
predictive information on nanoparticle uptake behaviour. Chitosan, a positively charged natural 
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polymer (20, 21), showed interesting physical and biological properties for the preparation of drug 
delivery systems. Moreover, the cytotoxicity of chitosan and its derivatives toward tumor cells has 
been reported by several authors (22-28). Interestingly, cationic chitosan nanoparticles have been 
already exploited as effective nanocarriers due to their ability to be easily internalized by different 
cell types (29-31). Previously, our group prepared 5-fluorouracil-loaded chitosan nanoparticles, able 
to increase the cytotoxicity of the drug in vitro (32). OLN, comprising 2H,3Hdecafluoropentane 
core, represent an innovative nanodevice developed using chitosan as shell component. As the 
present study shows, OLN were significantly internalized in vitro by TUBO breast cancer cells, 
inducing a high cytotoxic activity on this cell line. The OLN uptake by tumor cells can be described 
as a twostep process, comprising firstly their binding on the cell membrane by electrostatic 
interactions (33) and their subsequent internalization. As previously demonstrated, the larger the 
zeta potential of the nanoparticles, the stronger the interactions with tumor cell membrane, 
favouring the internalization and leading to more severe cytotoxicity. The cationic chitosan can 
remarkably affects the cell uptake since the positively charged amino groups of chitosan can 
establish electrostatic interactions with the negatively charged groups exposed on the membrane of 
tumor cells (34). Therefore, the high surface charge of about 45 mV of OLN might appear a likely 
cause for their cytotoxic activity. Several studies have demonstrated that chitosan can induce cell 
death by promoting necrosis (22, 23) or by inducing apoptosis (27, 28) depending on cancer cell 
type. Cells undergoing apoptosis express cell surface molecules which promote their removal by 
neighbouring phagocytes. On the other hand, necrotic cells are not generally removed as intact cells 
and their degradation often causes inflammation (35). OLN appear to exert per se a cytotoxic 
activity on TUBO cells in vitro by inducing apoptosis, but not necrosis, mediated cell death. They 
are, therefore, likely to avoid the triggering of the inflammatory responses. 
OLN did not affect the cell cycle kinetics of TUBO cells. However, OLN induced an increase of 
ROS levels. Various studies showed that ROS can be produced in different cell compartments and 
are able to damage by oxidation proteins, lipids and DNA (36, 37). Nanoparticles can induce 
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physico-chemical oxidative stress in mammalian cells by unbalancing the cellular ROS production 
over the cellular antioxidant defenses through mechanisms still not completely known. 
The critical role of ROS in nanoparticle-mediated cytotoxicity and genotoxicity has been reported 
by several researchers (38-42). The molecular oxygen content of OLN did not produce singlet 
oxygen. The oxidation capability of OLN was evaluated using a lipo-peroxidation assay on 
linolenic acid, incorporated in liposomes to mimic the membrane phospholipid bilayer. After the 
exposure to OLN the linolenic acid did not underwent to lipid peroxidation. Indeed, the oxygen 
loaded within OLN was not able to induce a direct lipo-peroxidation (data not shown). These results 
are in line with the previous data reported by Magnetto et al (7). 
The oxygen content of the OLN might affect apoptotic effect with a different mechanism. 
A hypothesis to explain oxygen toxicity might be related to the partial pressure increase of oxygen 
inside the tumor cells (43). 
As a matter of fact, oxygen toxicity was detected in case of hyperoxia (e.g. larger fraction of 
inspired oxygen) at atmospheric pressure or in hyperbaric conditions. The slow diffusion of 
oxygen from the OLN, together with its low solubility in the intracellular fluid both in-vitro and in-
vivo prevents any even transitory condition of hyperoxia. 
More than oxygen itself, the interaction of the internalized OLN within the cells may affect 
mitochondrial respiration, alter the endoplasmatic reticulum activity and also the plasma membrane 
with its enzyme complexes, including NADPH oxidases or finally activate immune cells. All the 
above mechanisms can lead to the production of free radicals and be therefore responsible for the 
toxic effects. 
Based on these results OLN might be considered an adjuvant for combination therapy. 
The proposed mathematical model, which accounts for the internalization of OLN into the TUBO 
cells and the subsequent induction of toxicity, satisfactorily explain the experimental in vitro and in 
vivo results and shows once again that a nanoparticle effective uptake from cells plays a crucial role 
and should be promoted or enhanced in vivo by proper targeting approaches. 
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Conclusions 
In this study we validate a computational models predicting the effects of OLN on the in vitro and 
in vivo growth of TUBO breast cancer cells after investigating OLN cellular internalization, 
cytotoxicity, antitumor efficacy, and the underlying biological mechanisms. Such a model may have 
many useful applications, since in the last years nanotechnology formulations have been extensively 
explored looking forward new possible treatments for several diseases, including cancer. 
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Tables 
 
Table I  
 
 
 
 
Average diameter ± SD [nm] PDI Z-potential ± SD [mV] pH 
379.25 ± 34.4 0.289 45.39 ± 1.02 5.00 
Physico-chemical characterization of the Blank chitosan-shelled/decafluoropentane-cored OLN 
formulations. Each point represents the mean ± SD of four different formulations (n=4). 
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Figure legends 
 
Figure 1. TEM image of OLN (magnification 39,000×). Scale bar, 300 nm. 
 
 
Figure 2. In vitro oxygen release from OLN formulations over time measured by an oximeter. 
Mean (± S.D.) of the relative (fold change) % oxygen released from OLN of four different 
formulations (n=4). 
 
Figure 3. OLN internalization by TUBO cells.  
TUBO cells were untreated (upper panels, Control) or treated with 10 % v/v FITC-labeled OLN 
(lower panels) for 24 h. After DAPI staining, cells were checked by confocal microscopy. Results 
are shown as representative images from three independent experiments. Left panels: cell nuclei 
after DAPI staining (blue). Central panels: FITC-labeled OLN (green). Right panels: merged 
images. Magnification: 63X. 
 
Figure 4. 
A_Analysis of OLN-induced necrosis on TUBO cells. TUBO cells were untreated or treated with 
increasing doses of OLN (2.5 %, 5%, 10% v/v) for 48 hours. The percentage of necrotic cells was 
measured by LDH assay. Results are shown as means±SD from three independent experiments.  
B_ Analysis of OLN induced cell death on TUBO cells. TUBO cells were untreated or treated 
with increasing doses of OLN (2.5 %, 5%, 10% v/v) for 48 hours. Apoptosis was assessed by 
evaluating the accumulation of hypodiploid cells, characterized by a subG1 DNA fluorescence. The 
percentage of hypodiploid cells was measured by flow cytometry assay. Results are shown as 
means±SD from three independent experiments. Significance of the differences vs untreated cells 
(0% v/v OLN): ** p<0.005;*** p<0.001. 
C_ Cell Cycle results. OLN did not cause any differences compared to controls in none of TUBO 
cell cycle phases (S, G0/G1, and G2/M). 
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D_ OLN effects on TUBO cell cycle distribution. TUBO cells were untreated or treated with 
increasing doses of OLN (2.5 %, 5%, 10% v/v) for 48 hours. OLN effects on cell cycle distribution 
were investigated measuring by flow cytometry the DNA content in S, G0/G1, and G2/M cell cycle 
phases. Data are presented as percentage of live cells in single cell cycle phases.  
E_ OLN induced ROS in TUBO cells. TUBO cells were untreated or treated with increasing doses 
of OLN (2.5 %, 5%, 10% v/v) for 24 hours. ROS generation was assessed by measurements of 
fluorescent activation of carboxy-H2DCFDA. ROS control value was arbitrary fixed to 1. Data are 
means+SD expressed as fold increase compared to untreated control. Significance of the differences 
vs untreated cells (0% v/v OLN): * p<0.01; ** p<0.005. 
 
Figure 5. Antitumor response elicited in BALB/c mice by OLN. The protection was evaluated 
against TUBO cells in the absence (Ctrl, solid lines n=5) or in the presence (OLN, dotted lines, n=5) 
of 10% v/v c-OLN. Each line refers to an individual tumor.  
 
Figure 6. In vitro experimental results of MTT. MTT evaluated (points) and simulated (lines) 
after 24, 48 and 72 hrs at 4 different concentrations (2.5 %, 5%, 10%, 20% v/v).  
 
Figure 7. In vivo data. Tumor growth in control mice and after OLN 10% v/v administration 
experimental evaluated (blue line for control group and red points for treated mice) compared to 
model simulated data (dotted lines) using the parameter values validated on the in vitro model. 
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